Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Economic benefits of treating medication-overuse headache - results from the multicenter COMOESTAS project

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. PACAP27 induces migraine-like attacks in migraine patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The spectrum of cluster headache: A case report of 4600 attacks

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Verapamil and Cluster Headache: Still a Mystery. A Narrative Review of Efficacy, Mechanisms and Perspectives

    Research output: Contribution to journalReviewResearchpeer-review

  2. The spectrum of cluster headache: A case report of 4600 attacks

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Sleep in cluster headache revisited: Results from a controlled actigraphic study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Calcitonin-gene related peptide and disease activity in cluster headache

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Disturbed sleep in cluster headache is not the result of transient processes associated with the cluster period

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Medication-overuse headache is a costly disease for individuals and society.

OBJECTIVE: To estimate the impact of medication-overuse headache treatment on direct and indirect headache-related health care costs.

METHODS: This prospective longitudinal study was part of the COMOESTAS project (COntinuous MOnitoring of Medication Overuse Headache in Europe and Latin America: development and STAndardization of an Alert and decision support System). Patients with medication-overuse headache were included from four European and two Latin American headache centers. Costs of acute medication, costs of health care services, and measurements of productivity were calculated at baseline and at 6-month follow-up Treatment consisted of overused drug withdrawal with optional preventive medication.

RESULTS: A total of 475 patients (71%) completed treatment and were followed up for 6 months. Direct health care costs were on average reduced significantly by 52% ( p < 0.001) for the total study population. Significant reductions were seen in both number of consumed tablets (-71%, p < 0.001) and number of visits to physicians (-43%, p < 0.001). Fifty percent of patients reduced their number of consumed tablets ≥ 80%. Headache-related productivity loss, calculated either as absence from work or ≥ 50% reduction of productivity during the workday, were reduced by 21% and 34%, respectively ( p < 0.001).

CONCLUSION: Standardized treatment of medication-overuse headache in six countries significantly reduced direct health care costs and increased productivity. This emphasizes the importance of increasing awareness of the value of treating medication-overuse headache.

TRIAL REGISTRATION: The trial was registered at ClinicalTrials.gov (no. NCT02435056).

Original languageEnglish
JournalCephalalgia : an international journal of headache
Volume39
Issue number2
Pages (from-to)274-285
Number of pages12
ISSN0333-1024
DOIs
Publication statusPublished - 2019

ID: 56703945